Search for: "Watson Pharmaceuticals Inc."
Results 101 - 120
of 224
Sort by Relevance
|
Sort by Date
22 Feb 2012, 7:37 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010) (A company “can readily protect itself by securing a clear written agreement. [read post]
19 Feb 2012, 8:55 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories Inc. [read post]
13 Feb 2012, 12:54 pm
Watson Laboratories, Inc., C.A. [read post]
27 Jan 2012, 2:21 pm
A. [read post]
10 Jan 2012, 12:43 pm
Mamula, Reporter for the Pittsburgh Business Times: Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs have sued generic drugmaker Mylan Inc. for patent infringement in connection with its plans to market pioglitazone hydrochloride and extended release metformin hydrochloride tablets, Canonsburg-based Mylan announced Monday. [read post]
8 Jan 2012, 9:05 pm
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
4 Dec 2011, 8:52 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. [read post]
1 Dec 2011, 2:02 pm
Coincidence, But Ironic, Given Several Recent Medical Studies Which Suggest Drospirenone (DRSP) Causes Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) On November 29, 2011 Watson Pharmaceuticals issued this press release, "Watson's Generic Yaz(R) Receives FDA Approval", which begins as follows: Watson Pharmaceuticals, Inc. [read post]
1 Dec 2011, 3:58 am
Ranbaxy's Lipitor-copy goes on sale 1 Dec 2011, but the impact on consumers is a bit more complicated than one might think.For example, Watson Pharmaceuticals is selling a Lipitor copy under an agreement made with patentee Pfizer (thus, an authorized generic). [read post]
3 Nov 2011, 9:55 am
Watson Pharmaceuticals, Inc., 629 F. [read post]
1 Nov 2011, 6:08 am
Inc. have experienced problems. [read post]
14 Oct 2011, 6:10 pm
Orange County - Noven Pharmaceuticals, Inc. has filed an action for patent infringement against Watson Pharmaceuticals, Inc. in a federal district court in New Jersey. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
9 Oct 2011, 9:37 pm
• Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc.; Watson Pharma Inc.; Watson Laboratories Inc. - Florida Infringement of U.S. [read post]
1 Sep 2011, 5:10 pm
IMS Health Inc (23 June 2011) in which the Court voted 6-3 to strike down Vermont’s Prescription Confidentiality Law, which had prohibited the use, sale or disclosure of prescriber histories in pharmaceutical marketing to physicians. [read post]
25 Aug 2011, 3:42 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
24 Aug 2011, 12:03 pm
Barr Pharmaceuticals settled a similar case last year and Watson/Schein Pharmaceuticals Inc. reportedly anticipates an imminent settlement. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) –… [read post]
18 Jul 2011, 5:16 pm
Circuit’s March 2, 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
